Abstract: An information processing apparatus includes a controller. The controller performs a transfer source information generation process for generating transfer source information upon reception of an offload data transfer instruction from a host computer. The controller performs a reserved state setting process for setting, when an instruction to release a release area is received, an overlapping area to a reserved state so as to reserve release of the overlapping area, after issuing a completion response for the release instruction. The controller performs a pending state determination process for determining a pending state in which data transfer using the transfer information might be executed. The controller performs an area release process for releasing the overlapping area which is set to the reserved state and thus is reserved to be released, when the pending state is cancelled.

Abstract: A storage controller including a processor, wherein the processor: performs a copy process in which a destination virtual volume is created by copying a source virtual volume in accordance with a copy instruction, performs a release process in which allocation of a destination storage area to a corresponding area of the destination virtual volume that corresponds to an unallocated area to which a source storage area is not allocated, among areas of the source virtual volume at a time point when the copy instruction is received is released in the copy process, specifies a corresponding area that is an unallocated area including one or more update areas updated before the copy process and the release process after the copy instruction among one or more unallocated areas of the source virtual volume, and suppresses the release relating to the corresponding area that corresponds to the specified unallocated area.

Abstract: A calculation method includes obtaining a temporal sequence of position data representing movement loci of an agricultural machine; extracting from among the obtained sequence of position data, a set of position data representing an interval among the movement loci of the agricultural machine and in which slopes of segments connecting two points represented by consecutive position data among the sequence of position data are consecutively within a given range; and calculating based on the extracted set of position data representing the interval, a length of a work interval of agricultural work performed by the agricultural machine. The calculation method is executed by a computer.

Abstract: A storage apparatus performs, in place of a copy process which involves physical resource allocation to a copy destination logical volume, a copy process which allows the copy destination logical volume to refer to an allocation destination managed by a management unit area of a copy source logical volume. A storage unit stores management information relating to the reference destination of the management unit area of the logical volume. A control unit releases the physical resource which has been allocated to the management unit area by exchanging the reference destination of the management unit area specified by a release command from a host computer with the reference destination of the management unit area of the other logical volume corresponding to the specified management unit area.

Abstract: An information processing apparatus includes a controller. The controller performs a transfer source information generation process for generating transfer source information upon reception of an offload data transfer instruction from a host computer. The controller performs a reserved state setting process for setting, when an instruction to release a release area is received, an overlapping area to a reserved state so as to reserve release of the overlapping area, after issuing a completion response for the release instruction. The controller performs a pending state determination process for determining a pending state in which data transfer using the transfer information might be executed. The controller performs an area release process for releasing the overlapping area which is set to the reserved state and thus is reserved to be released, when the pending state is cancelled.

Abstract: A farming support method includes accepting input of information indicating a state of a crop or information indicating a state of an environment, and extracting, from a first storage unit that stores restriction information including a condition related to the state of the crop or the state of the environment and a work instruction for a case in which the condition is satisfied, the restriction information having the condition matching the information indicating the state of the crop or the information indicating the state of the environment that is input. The method further includes judging, using a second storage unit that stores a judgement result on whether to adopt each restriction information for each cultivation example of the crop, whether to adopt the restriction information that is extracted.

Abstract: A presence communication system capable of efficiently reducing the number of messages exchanged between presentities and watchers, thereby preventing lowering in communication quality. A presence server sets a group identifier as an identifier which is used to collectively look up a group of multiple pieces of presence information provided by presence information providers who have agreed to a use policy, aggregates and stores the presence information under the group identifier, and delivers the presence information requested to the group identifier. Each presentity provides the presence server with its presence information targeted to the group identifier. Each watcher requests the group identifier for the presence information provided by the presentities, and receives the presence information delivered from the presence server.

Abstract: In a pressure-sensitive adhesive composition or a pressure-sensitive adhesive sheet containing an energy ray-curable polymer, problems associated with the volatilization of a low molecular weight compound contained in the composition are overcome. An energy ray-curable polymer characterized by comprising a radical generating group, which is capable of initiating a polymerization reaction upon excitation with an energy ray, and an energy ray-polymerizable group bonded together in the main or side chain.

Abstract: In a pressure-sensitive adhesive composition or a pressure-sensitive adhesive sheet containing an energy ray-curable polymer, problems associated with the volatilization of a low molecular weight compound contained in the composition are overcome. An energy ray-curable polymer characterized by comprising a radical generating group, which is capable of initiating a polymerization reaction upon excitation with an energy ray, and an energy ray-polymerizable group bonded together in the main or side chain.

Abstract: This invention relates to novel amide derivatives and salts thereof. More particularly, it relates to novel amide derivatives and salts thereof which act as a ROCK inhibitor, to a pharmaceutical composition comprising the same and to a method of using the same therapeutically in the treatment and/or prevention of ROCK-related disease.

Abstract: An adhesive sheet includes a substrate and an energy-ray curable adhesive layer formed on the substrate. The energy-ray curable adhesive layer includes an energy-ray curable acrylic copolymer and a urethane acrylate. The energy-ray curable acrylic copolymer is formed by copolymerizing at least one of either a dialkyl(meth)acrylamide that has an alkyl group with carbon number of not more than 4, a phenol EO modified (meth)acrylate that has an ethylene glycol chain with a phenyl group bonded to the ethylene glycol chain, a (meth)acryloyl morpholine, or a (meth)acrylate that has an aceto-acetoxyl group, in total of 1 to 30 weight percent of all monomers to form the energy-ray curable acrylic copolymer. The energy-ray curable acrylic copolymer further includes a side chain with an unsaturated group.

Abstract: [Problem] The present invention provides a condensed pyrrolopyridine derivative which is useful as an active ingredient for a pharmaceutical composition, in particular, a pharmaceutical composition for preventing or treating diseases caused by undesirable cytokine signal transduction or diseases caused by abnormal cytokine signal transduction. [Means for Solution] The present inventors have extensively studied a compound having a JAK inhibitory action, and as a result, they have found that a condensed pyrrolopyridine derivative which is the compound of the present invention has an excellent JAK inhibitory action, and is therefore useful as an agent for preventing or treating diseases caused by undesirable cytokine signal transduction or diseases caused by abnormal cytokine signal transduction, thereby completing the present invention.

Abstract: A manufacturing method of a semiconductor device according to the present invention comprises: laminating a surface protective sheet to a circuit surface side of a wafer formed with grooves which divide each circuit wherein an adhesive film is adhered on the circuit surface of the wafer; reducing the thickness of the wafer and finally dividing the wafer into individual chips by grinding a back face of the wafer; picking up individual chips together with the adhesive film; die-bonding said individual chip to predetermined position of a chip mounting substrate via said adhesive film; fixing the chip to the chip mounting substrate by heating the die-bonded chip having the adhesive film; and applying a static pressure larger than an ambient pressure by 0.05 MPa or more to a stacked body including the adhesive film one or more times, at any point between adhering the wafer to the adhesive film and fixing the chip to the chip mounting substrate.

Abstract: An adhesive sheet includes a substrate and an energy-ray curable adhesive layer formed on the substrate. The energy-ray curable adhesive layer includes an energy-ray curable acrylic copolymer and a urethane acrylate. The energy-ray curable acrylic copolymer is formed by copolymerizing at least one of either a dialkyl(meth)acrylamide that has an alkyl group with carbon number of not more than 4, a phenol EO modified (meth)acrylate that has an ethylene glycol chain with a phenyl group bonded to the ethylene glycol chain, a (meth)acryloyl morpholine, or a (meth)acrylate that has an aceto-acetoxyl group, in total of 1 to 30 weight percent of all monomers to form the energy-ray curable acrylic copolymer. The energy-ray curable acrylic copolymer further includes a side chain with an unsaturated group.

Abstract: This invention relates to novel heterocyclic carboxamide derivatives and salts thereof. More particularly, it relates to novel heterocyclic carboxamide derivatives and salts thereof which act as a ROCK inhibitor, to a pharmaceutical composition comprising the same and to a method of using the same therapeutically in the treatment and/or prevention of ROCK-related disease.

Abstract: Provided is a compound which is useful as an active ingredient for a pharmaceutical having a PKC? inhibition activity, particularly a pharmaceutical composition for inhibiting acute rejection occurring in transplantation. The present inventors have conducted extensive studies on a compound having a PKC? inhibition activity, and as a result, they have found that a compound having a structure such as aralkyl and the like on an amino group at the 2-position and also having a structure such as an adamantylalkyl group and the like on an amino group at the 4-position of 2,4-diaminopyrimidine, or a salt thereof has an excellent PKC? inhibition activity, thereby completing the present invention. The 2,4-diaminopyrimidine compound of the present invention can be used as a PKC? inhibitor or an inhibitor of acute rejection occurring in transplantation.

Abstract: In a pressure-sensitive adhesive composition or a pressure-sensitive adhesive sheet containing an energy ray-curable polymer, problems associated with the volatilization of a low molecular weight compound contained in the composition are overcome. An energy ray-curable polymer characterized by comprising a radical generating group, which is capable of initiating a polymerization reaction upon excitation with an energy ray, and an energy ray-polymerizable group bonded together in the main or side chain.

Abstract: An adhesive sheet includes a substrate and an energy-ray curable adhesive layer formed on the substrate. The energy-ray curable adhesive layer includes an energy-ray curable acrylic copolymer and a urethane acrylate. The energy-ray curable acrylic copolymer is formed by copolymerizing at least one of either a dialkyl(meth)acrylamide that has an alkyl group with carbon number of not more than 4, a phenol EO modified (meth)acrylate that has an ethylene glycol chain with a phenyl group bonded to the ethylene glycol chain, a (meth)acryloyl morpholine, or a (meth)acrylate that has an aceto-acetoxyl group, in total of 1 to 30 weight percent of all monomers to form the energy-ray curable acrylic copolymer. The energy-ray curable acrylic copolymer further includes a side chain with an unsaturated group.

Abstract: A context information collection and distribution system registers read identification information in a computer device that manages and controls an RFID tag reading device and is located in a lowest hierarchy in wide area network topology. The computer device located in the lowest hierarchy in the wide area network topology notifies a computer device located in a higher management domain hierarchy that the computer device located in the lowest hierarchy manages read identification information of a target. Further, the computer device located in the management domain hierarchy notifies a computer device located in much higher ID system hierarchy that the computer device located in the hierarchy just under the management domain hierarchy manages the read identification information of the target.

Abstract: To provide a compound usable for treatment of diseases associated with fatty acid amide hydrolase (FAAH), especially for treatment of urinary frequency and urinary incontinence, overactive bladder and/or pain. We have found that a novel pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate derivative and its pharmaceutically acceptable salt has a potent FAAH-inhibitory activity. Further, the pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate derivative of the present invention has an excellent effect for increasing an effective bladder capacity, an excellent effect for relieving urinary frequency and an excellent anti-allodynia effect, and is therefore usable for treatment of urinary frequency and urinary incontinence, overactive bladder and/or pain.